Takeda Pharmaceutical Co Ltd ADR (TAK)
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Takeda Pharmaceutical Co Ltd ADR is a Healthcare company with a market capitalization of $55.20B and a dividend yield of 1.85%.
5-Year Price History
Latest Annual Financials · FY ending March 31, 2026 · in JPY
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q3 2026 | January 29, 2026 | $0.21 | — | — |
| Q2 2026 | October 30, 2025 | $-0.03 | $0.15 | -116.8% |
| Q1 2026 | July 30, 2025 | $151.00 | $0.20 | +75174.2% |
| Q4 2025 | June 25, 2025 | $-0.23 | $-0.17 | -37.1% |
| Q3 2025 | January 30, 2025 | $0.05 | $0.63 | -92.4% |
| Q2 2025 | October 31, 2024 | $29.07 | $87.45 | -66.8% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 3,817,076 | — | 1.3 | -27.4% |
| June 30, 2026 | 5,260,746 | — | 1.9 | -2.0% |
| June 15, 2026 | 5,367,615 | — | 1.6 | +10.0% |
| May 29, 2026 | 4,881,647 | — | 1.6 | +25.9% |
| May 15, 2026 | 3,876,844 | — | 1.1 | -22.4% |
| April 30, 2026 | 4,996,263 | — | 2.0 | +5.5% |
| April 15, 2026 | 4,734,092 | — | 1.5 | -30.7% |
| March 31, 2026 | 6,834,466 | — | 2.3 | +16.3% |
Other Drug Manufacturers - Specialty & Generic Stocks
Frequently Asked Questions
What is Takeda Pharmaceutical Co Ltd ADR's market cap?
As of August 13, 2026, Takeda Pharmaceutical Co Ltd ADR (TAK) has a market capitalization of $55.20B.
Does Takeda Pharmaceutical Co Ltd ADR pay a dividend?
Yes — Takeda Pharmaceutical Co Ltd ADR pays a dividend yielding 1.85%, an annual payout of $200.00 per share.
What sector is TAK in?
Takeda Pharmaceutical Co Ltd ADR is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
What is Takeda Pharmaceutical Co Ltd ADR's short interest?
As of the July 15, 2026 FINRA settlement, 3,817,076 TAK shares were sold short. Days to cover: 1.3. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Takeda Pharmaceutical Co Ltd ADR's revenue?
In its latest reported fiscal year (ending March 31, 2026), Takeda Pharmaceutical Co Ltd ADR reported revenue of 4.78T JPY and net income of 203.33B JPY.
Ask your own questions about TAK
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.